| Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma R Wang, M Dang, K Harada, G Han, F Wang, M Pool Pizzi, M Zhao, ... Nature medicine 27 (1), 141-151, 2021 | 157 | 2021 |
| Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response R Wang, S Song, K Harada, FG Amlashi, B Badgwell, MP Pizzi, Y Xu, ... Gut 69 (1), 18-31, 2020 | 127 | 2020 |
| YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition JA Ajani, Y Xu, L Huo, R Wang, Y Li, Y Wang, MP Pizzi, A Scott, K Harada, ... Gut 70 (1), 55-66, 2021 | 58 | 2021 |
| Targeting angiogenesis in colorectal carcinoma A Lopez, K Harada, M Vasilakopoulou, N Shanbhag, JA Ajani Drugs 79, 63-74, 2019 | 55 | 2019 |
| Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma S Song, Q Chen, Y Li, G Lei, A Scott, L Huo, CY Li, JS Estrella, A Correa, ... Gut 70 (12), 2238-2248, 2021 | 40 | 2021 |
| Recent advances in the management of gastric adenocarcinoma patients K Harada, A Lopez, N Shanbhag, B Badgwell, H Baba, J Ajani F1000Research 7, 2018 | 35 | 2018 |
| Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose … RL Katz, TM Zaidi, D Pujara, ND Shanbhag, D Truong, S Patil, RJ Mehran, ... Cancer cytopathology 128 (8), 553-562, 2020 | 33 | 2020 |
| Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma S Song, Y Li, Y Xu, L Ma, M Pool Pizzi, J Jin, AW Scott, L Huo, Y Wang, ... Molecular oncology 14 (6), 1410-1426, 2020 | 31 | 2020 |
| Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, ... Gut 70 (11), 2055-2065, 2021 | 25 | 2021 |
| Palliative care for advanced gastric cancer K Harada, M Zhao, N Shanbhag, H Baba, JA Ajani Expert review of anticancer therapy 20 (7), 575-580, 2020 | 25 | 2020 |
| Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, ... Gut 72 (4), 624-637, 2023 | 23 | 2023 |
| Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases K Harada, H Hwang, X Wang, A Abdelhakeem, M Iwatsuki, MAB Murphy, ... Gastric Cancer 23, 904-912, 2020 | 14 | 2020 |
| Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, ... Cancer cell 41 (8), 1407-1426. e9, 2023 | 13 | 2023 |
| Total lesion glycolysis assessment identifies a patient fraction with a high cure rate among esophageal adenocarcinoma patients treated with definitive chemoradiation K Harada, CC Wu, X Wang, DM Kaya, FG Amlashi, M Iwatsuki, ... Annals of surgery 272 (2), 311-318, 2020 | 13 | 2020 |
| Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma S Song, Y Xu, L Huo, S Zhao, R Wang, Y Li, AW Scott, MP Pizzi, Y Wang, ... Journal of Experimental & Clinical Cancer Research 40 (1), 207, 2021 | 11 | 2021 |
| Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma K Harada, H Hwang, X Wang, A Abdelhakeem, M Iwatsuki, MAB Murphy, ... Annals of surgery, 2019 | 10 | 2019 |
| Cancer stem cells in esophageal cancer and response to therapy K Harada, M Pool Pizzi, H Baba, ND Shanbhag, S Song, JA Ajani Cancer 124 (20), 3962-3964, 2018 | 10 | 2018 |
| Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells K Harada, M Patnana, X Wang, M Iwatsuki, MAB Murphy, M Zhao, P Das, ... Surgery today 50, 1223-1231, 2020 | 5 | 2020 |
| Ramucirumab and paclitaxel administered every 2 weeks (mRAINBOW Regimen) in advanced gastroesophageal adenocarcinoma JE Rogers, L Xiao, FG Amlashi, E Elimova, MA Blum Murphy, E Sanders, ... Oncology 96 (5), 252-258, 2019 | 5 | 2019 |
| GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, ... Journal of Experimental & Clinical Cancer Research 41 (1), 257, 2022 | 4 | 2022 |
